// App-Quantinova.ai

OC 62.3 : Apixaban for venous thromboembolism treatment in obese patients with weight >120kg or BMI >40 kg m2

Researchers

Presenter

  • T. Groves

Principal Investigators

  • M. Rees

  • R. Alikhan

Medical Centers

  • Cardiff and Vale UHB, Cardiff, Wales, United Kingdom

  • Cardiff and Vale University Health Board, Cardiff, Wales, United Kingdom

  • Cardiff and Vale UHB, Cardiff, Wales, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Body mass index

Drug/Treatment

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved